KatherineElizabethTalcottMD

Ophthalmology • Cleveland, OH

Retinal Disease

Vitreoretinal Specialist, Cole Eye Institute, Cleveland Clinic

Join to view full profile

Dr. Talcott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Talcott's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195

Education & Training

Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2012 - 2015
Brigham and Women's HospitalInternship, Internal Medicine, 2011 - 2012
University of California San Francisco School of MedicineClass of 2011

Certifications & Licensure

MA State Medical License 2015 - 2026
OH State Medical License 2018 - 2025
PA State Medical License 2016 - 2018
American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Retrospective Cohort Study of Sickle Cell Disease and Large Vessel Retinal Vascular Occlusion Risk in a National United States Database.
Gabriel T Kaufmann, Matthew Russell, Priya Shukla, Rishi P Singh, Katherine E Talcott
Ophthalmology. Retina. 2025-01-01
Detection of Geographic Atrophy Guided by Optical Coherence Tomography Sub-RPE Illumination Analysis in Patients With Intermediate Age-Related Macular Degeneration.
Andrei Szigiato, Christopher M Maatouk, Alexander E Azar, Peter Alsaloum, Katherine E Talcott
Journal of Vitreoretinal Diseases. 2024-12-30
Evaluation of Sustained Intraocular Pressure Elevations Across Antivascular Endothelial Growth Factor Agents.
Neil A Rana, Meghana Chalasani, Jonathan Markle, Matthew W Russell, Ang Li
Journal of Vitreoretinal Diseases. 2024-12-13

Press Mentions

Spotlight on Expanded Field Imaging Findings in Proliferative Sickle Cell RetinopathySeptember 1st, 2024